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Objectives: Pulmonary hypertension is a serious disorder with catastrophic outcomes. This
study aimed to evaluate the effect of pulmonary arterial hypertension on the outcome
among new cases of pulmonary tuberculosis. Novel modalities are available as therapeutic
options, so early diagnosis of pulmonary arterial hypertension may be important.
Methods: In a cross-sectional study, 777 new cases of pulmonary tuberculosis were
recruited in the National Research Institute of Tuberculosis and Lung Disease, Tehran, Iran.
Pulmonary arterial pressure was measured by resting transthoracic echocardiography on
the beginning of tuberculosis treatment. Echocardiography was performed by a cardiologist
expert in the field. Patients with systolic pulmonary arterial pressure more than 35 mmHg
were defined as pulmonary hypertensive. The relationship between pulmonary arterial
hypertension and mortality was assessed during six months of tuberculosis treatment.
Results: Seventy-four (9.5%) of 777 new cases of pulmonary tuberculosis had pulmonary
arterial hypertension. Among them, 10 (13.5%) died during the treatment period. In com-
parison with 5% mortality among cases without pulmonary arterial hypertension, death
was significantly associated with pulmonary hypertension (P = 0.007). Logistic regression
analysis showed that pulmonary arterial pressure more than 35 mmHg is an independent
predictor of death among tuberculosis patients.
Conclusion: Among new cases of pulmonary tuberculosis, a significant association between
mortality and pulmonary arterial pressure >35 mmHg was found. Therapeutic intervention
may change the outcome of these patients.
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